The actual sold production of diagnostic reagents and other pharmaceutical preparations in Poland in 2023 stood at 5.0008 million Euros. Based on the forecasted data, we observe a steady increase in production value from 2024 to 2027. The year-on-year variation from 2023 to 2024 is 0.19%, from 2024 to 2025 is 0.19%, from 2025 to 2026 is 0.19%, and from 2026 to 2027 is 0.18%. The Compound Annual Growth Rate (CAGR) over the five-year period from 2023 to 2027 is approximately 0.19% annually.
Future trends to watch for include advancements in biotechnology and medical research which could significantly drive demand for diagnostic reagents and pharmaceutical preparations. Additionally, policy changes and funding allocations towards healthcare innovation in the EU may impact production volumes and market dynamics in Poland.
